Slowing insect resistance to genetically modified crops

Genetically modified Bt crops are now widely used in the USA.

These crops contain genes from bacteria that make them toxic to some insect pests. A central concern in regulating these genetically modified crops is the risk of insects evolving resistance to the Bt toxins.

To reduce this risk, the “high dose/refuge” strategy is now being used, in which non-Bt fields (refuges for insect pests) are planted near Bt fields (where there is high dose of toxin).

In the November issue of Ecology Letters, Ives and Andow use mathematical theory to explain how the high dose/refuge strategy works. This analysis leads to several unexpected results. For example, for some Bt crops and some pests, spraying insecticides in refuges should not severely compromise the value of refuges.

This makes the high dose/refuge strategy more practical by allowing farmers to protect their crops in refuges. The new theory could lead to new resistance management strategies.

Media Contact

Michael Hochberg EurekAlert!

All latest news from the category: Agricultural and Forestry Science

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…